
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
GAITHERSBURG, Md., October 23, 2026--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will rel…
